Compare MasTec Inc (MTZ) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MasTec Inc vs Health Care Select Sector SPDR Fund — how do they compare? MasTec Inc trades at $212.65 (market cap $17.40B), while Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 2.5× MasTec Inc's market cap, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, MasTec Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold MasTec Inc for 23 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| MTZ | XLV | |
|---|---|---|
Market Cap | $17.40B | $43.48B |
Volume | 1,415,821 | 11,121,431 |
Sector | Industrials | — |
52-Week High | $437.51 | $175.68 |
52-Week Low | $190.08 | $141.95 |
Typical Hold Time | 23 Days | 100 Days |
Enterprise Value | $20.32B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MasTec (MTZ) trades at $216.66, down 3.0% on the day, with technical indicators showing bearish momentum as the stock trades below key moving averages. The company reported strong Q1 2026 earnings beat but missed Q2 expectations, while maintaining robust revenue growth projections for 2026. Analyst sentiment remains overwhelmingly positive with 89% buy ratings and a consensus price target of $408.58, representing significant upside potential from current levels.
MTZ presents a compelling growth story with record $21.4B backlog and exposure to infrastructure investment cycles, though premium valuation metrics and recent cash flow weakness warrant caution. The stock's current discount to analyst targets offers opportunity, but execution risks in communications segment and competitive pressures require monitoring.
XLV trades at $168.16, down 0.39% with a bearish technical signal from moving averages. The healthcare ETF maintains strong cost advantages with a 0.08% expense ratio compared to peers. Recent news highlights XLV's defensive positioning during market volatility and its historical outperformance during Fed rate hikes. Technical indicators show RSI levels in neutral territory while ADX signals selling pressure.
XLV offers diversified healthcare exposure with competitive expense ratios, positioning it well for defensive investing. Key risks include political uncertainty around healthcare policy and concentrated exposure to domestic S&P 500 stocks. The ETF's low-cost structure and sector diversification provide stability amid market volatility, though technical indicators suggest near-term caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About MasTec Inc
MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.
Read more on MTZ →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
